Despite the high prevalence of addiction and substance use disorders in the United States, the number of physicians adopting evidence-based substance use disorder interventions in their clinical practice remains low.
Ginkgo, Novo Nordisk forge ‘flexible’ research pact, from discovery to manufacturing
Ginkgo Bioworks is expanding its original research partnership with Novo Nordisk to cover the entire value chain. The new pact is a “flexible and scalable”
April 11, 2024